Cart
sales@molnova.com
Home - Products - Others - Other Targets - Cbl-b-IN-5

Cbl-b-IN-5

CAS No. 2368835-59-8

Cbl-b-IN-5( —— )

Catalog No. M36958 CAS No. 2368835-59-8

Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 116 Get Quote
5MG 178 Get Quote
10MG 278 Get Quote
25MG 548 Get Quote
50MG 1003 Get Quote
100MG 1404 Get Quote
500MG 2817 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Cbl-b-IN-5
  • Note
    Research use only, not for human use.
  • Brief Description
    Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.
  • Description
    Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 μM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2368835-59-8
  • Formula Weight
    339.42
  • Molecular Formula
    C17H17N5OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (294.63 mM; Ultrasonic )
  • SMILES
    O=C(NC1=CC=CC(=C1)C(SC2=NN=CN2C)C)C3=NC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • (R)-Carisbamate

    (R)-Carisbamate is the R-isomer of Carisbamate .?Carisbamate is an experimental anticonvulsant drug.

  • Obtustatin

    Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chorioallantoic model. Displays antitumor efficacy in a synergistic mouse model of Lewis lung carcinoma; blocks human melanoma growth in nude mice.

  • Bacopaside N1

    Bacopaside N1 is a diglycosidic saponin.

Sign In Join Free